Ketamine-Assisted Therapy

EXCLUSIVE: Mindbloom's Mastermind Series, A Psychedelic Therapy Program For Heartbreak, Burnout & Parallel Challenges
UK Psychedelics: Phase 3 Depression & Alcohol Addiction Trials, New London Center
Ketamine Company Acquisition Alert: Beckley Waves Adds Nue Life To Its Portfolio
UK Psychedelics: Phase 3 Depression & Alcohol Addiction Trials, New London Center
Ketamine Company Acquisition Alert: Beckley Waves Adds Nue Life To Its Portfolio
Psychedelics Firm Optimind Pharma Sustains Growth Plan Rollout With New Acquisition
PsychMD's Nationwide, Safe-Supplied AI-Driven Ketamine Therapy With US Vets In Mind

Ketamine-Assisted Therapy Recent News

Are You One Of The Lucky 50,000? New Pact Opens Psychedelic Treatment Floodgates
Ketamine clinics operator Revitalist Lifestyle & Wellness Ltd. (OTCQB: RVLWF) and psilocybin bioscience and wellness platforms company Wake Network have partnered with GCM Partners LLC to offer new ketamine treatment locations in two facilities in Chicago, two in Orlando and one in Miami. 
EXCLUSIVE: NYC Ketamine Center Co-Founder On Prices, Insurance, Competition & Expansion
This is the third article of a three-part series, you can find the first and
EXCLUSIVE: Ketamine Therapy Provider Nushama Co-Founder On Shifting From A Consciousness Of Blame Into A Space Of Responsibility
In light of the latest news regarding the DEA’s telehealth regulations and the 
EXCLUSIVE: NYC's Ketamine Therapy Provider Nushama Talks Integration, Safety & Holistic Care
(Part one of three.)
Awakn's Ketamine Treatment For Alcohol Use Disorder Awarded UK's Fast-Track Status
Awakn Life Sciences Corp. (OTCQB: AWKNF), a biotech company developing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder (AUD), has been granted an Innovation Passport for its proprietary Ketamine-Assisted Therapy (KAT) to treat severe AUD.
Cybin Touts Promising Results From Sponsored Kernel Flow Study Measuring Psychedelic Effects On The Brain
Cybin Inc.
UK Supports Psychedelic Research With Phase 3 Trial In Federal Health Sites
Awakn Life Sciences Corp.
Free Ketamine Therapy? Laid Off Tech Workers Can Request Month Of 'Freedom' Program
A considerable number of employees have been fired from their jobs at big tech firms.
Europe To Have Expanded Access To Psychedelic-Assisted Therapy With New Norway Clinic
Psychedelics biotech Awakn Life Sciences Corp.
A Leading Ketamine Treatment Clinic For Alcoholism Is Expanding: Here's The Latest
A psychedelics R&D biotech company, known for providing novel treatments for addictions, is opening a new ketamine clinic. 
Psychedelics And Treatment-Resistant Depression: Companies Weigh In On The Important Issue
(Part three of a four-part series) Have a look at previous stories:
Psychedelic-Assisted Psychotherapy And Telehealth Platforms Merge To Enhance Treatment Options
Psychedelic medicine and telehealth provider TripSitter Clinic Ltd. has closed the acquisition of assets of Insight Systems PBC -aka Reconscious Medical-, a psychedelic psychotherapy company engaging in both in-clinic and online virtual care with safety, monitoring and support provided via a novel technology platform.
Florida Ketamine Therapy Provider Launches Non Profit To Offer Affordable Psychedelic Treatments
MY Self Wellness, a mental health and wellness center offering psychedelics-assisted therapy,  announced the launch of the nonprofit organization Warriors of Consciousness to help make ketamine treatments more affordable for those in need.
EXCLUSIVE: New Partnership Brings Leading Psychedelic Protocol For Alcoholism Treatment To NYC
NYC-based clinics brand Nushama has partnered with Awakn Life Sciences (OTCQB: AWKNF), a clinical-stage psychedelics biotech company to bring
Florida's Growing Psychedelic Treatment Options: Healthcare Company Expands Network Of Clinics
Senior health brand Irwin Naturals Inc.
At Home-Ketamine Therapy Platform: What's It All About?
Psychedelics mental wellness telehealth company Nue Life Health PBC is now offering Nue Care, a personalized six-month aftercare program to treat the root causes of mental health disorders with personal sessions, progress tracking, health coaching, integration support and supplements towards reducing the dependence on long-term pharmacotherapy.
Intradermal Ketamine Patch Completes Pre-Clinical Phase, Advances To Clinical Studies
PharmaTher Holdings (OTCQB: PHRRF), the biopharma company developing novel uses and delivery forms of ketamine for mental health treatments, has completed an IND-enabling pharmacokinetic and tolerability study of its ketamine patch, KETARX, in minipigs. 
Awakn Life Sciences: Business And Corporate Update For Psychedelics Biotech
Biotech psychedelics company Awakn Life Sciences Corp. (OTCQB: AWKNF) has just published its business and corporate updates.

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved